Prednisone Tablets USP — Class II drug recall D-1330-2022
Terminated recall by Strides Pharma Inc., reported 2022-08-17, distributed nationwide. Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets
| Recall number | D-1330-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Strides Pharma Inc., East Brunswick, NJ, United States |
| Recall initiated | 2022-07-19 |
| Classified | 2022-08-09 |
| Reported by FDA | 2022-08-17 |
| Terminated | 2023-06-21 |
| Distributed | Nationwide (US) |
| Quantity | 1,032 bottles |
| NDC | 64380-0784, 64380-0784-01, 64380-0784-06, 64380-0784-07, 64380-0784-08, 64380-0785, 64380-0785-01, 64380-0785-06, 64380-0785-07, 64380-0785-08, 64380-0949, 64380-0949-01, 64380-0949-06 |
| Lot numbers | 7248988B |
| Expiration dates | 2023-09 |
Product
Prednisone Tablets USP, 20 mg, 100-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd., Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-785-06.
Reason for recall
Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1330-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.